Status: Recruiting
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
This study will evaluate the safety, tolerability and efficacy of E-islet 01 in participants with Type 1 diabetes mellitus (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia
Participants needed: 21
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: EndoCell Therapeutics, Inc.Updated: Aug 22, 2025Locations: 1
Eligibility criteria
Clinical history of Type 1 Diabetes with > 5 years of duration [+5]
Uncontrolled systemic infections, including but not limited to pulmonary tubercu... [+3]